about
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines based on its Vector Adjuvant Antigen Standardized Technology to protect against a wide range of infectious diseases. The products under i...
Read More
0.32
-0.11
(-25.58%)
23.8M
XNAS Volume
High volume+loss today
XNAS 07 Jul, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Vaxart Inc is on 08 Aug 2025 for the purpose of Vaxart Inc Second Quarter Earnings Results for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Bearish
Weak Stock
These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Vaxart Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..